Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03407287 · ClinicalTrials.gov registry record
Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- 180
- Enrollment target
NCT03407287: Clinical Trial study, sponsored by Vanderbilt University Medical Center.
NCT03407287 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03407287 was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- 180 participants
- Enrollment target
Study Summary
The aim of this study is to determine the effects of fluid alternations, hemodynamic changes, mechanical ventilation, pharmacologic agents, positional changes, and comorbidities on the Peripheral Intravenous waveform Analysis (PIVA) signal.
Primary Outcome
Peripheral intravenous waveform analysis score is used to detect intravascular volume status. The scale ranges from 2-40 and is interpreted as a surrogate for pulmonary capillary wedge pressure. The normal scale range is 6-12. A PIVA score of 2 indicates a low intravascular volume and 40 indicates a high intravascular volume.
Interventions
- PROCEDURE Peripheral Intravenous Analysis (PIVA)
- PROCEDURE Standard of care invasive vascular monitoring
- PROCEDURE Standard noninvasive vascular monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2020-12-01 |
Why NCT03407287 stopped before completion
NCT03407287 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Peripheral Intravenous Analysis (PIVA) is the first listed.
NCT03407287 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03407287 about?
NCT03407287 is a clinical study titled "Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status". The aim of this study is to determine the effects of fluid alternations, hemodynamic changes, mechanical ventilation, pharmacologic agents, positional changes, and comorbidities on the Peripheral Intravenous waveform Analysis (PIVA) signal.
What is the current status of trial NCT03407287?
This trial is currently terminated. The enrollment target is 180 participants. The study started on 2018-01-08. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT03407287?
The interventions under investigation include: Peripheral Intravenous Analysis (PIVA) (PROCEDURE), Standard of care invasive vascular monitoring (PROCEDURE), Standard noninvasive vascular monitoring (PROCEDURE).
Who is sponsoring clinical trial NCT03407287?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI